Cargando…
Cardio-Oncology Guidelines and Strength of the Evidence
Autores principales: | Zheng, Haoyi, Zhan, Huichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982203/ https://www.ncbi.nlm.nih.gov/pubmed/36875914 http://dx.doi.org/10.1016/j.jaccao.2022.12.001 |
Ejemplares similares
-
The ESC Cardio-Oncology Guidelines: A Roadmap for Clinical Practice and Generating Needed Evidence
por: Sparano, Joseph A., et al.
Publicado: (2022) -
The European Society of Cardiology Cardio-Oncology Guidelines: Evidence Base, Actionability, and Relevance to Clinical Practice
por: Leong, Darryl P., et al.
Publicado: (2022) -
Clinical Practice Guidelines in Cardio-Oncology: A Sea of Opportunity
por: Sase, Kazuhiro, et al.
Publicado: (2022) -
ESC Cardio-Oncology Guidelines: A Triumph—But Are We Overscreening?
por: Witteles, Ronald M., et al.
Publicado: (2022) -
The Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China
por: Tse, Gary, et al.
Publicado: (2023)